Drug Type Chemical drugs |
Synonyms SIM0532 |
Target |
Action inhibitors |
Mechanism RAS inhibitors(RAS type GTPase family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 16 Mar 2026 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 16 Mar 2026 | |
| Colorectal Cancer | Phase 1 | China | 16 Mar 2026 | |
| Colorectal Cancer | Phase 1 | China | 16 Mar 2026 | |
| Non-Small Cell Lung Cancer | Phase 1 | China | 16 Mar 2026 | |
| Non-Small Cell Lung Cancer | Phase 1 | China | 16 Mar 2026 | |
| Pancreatic Adenoma | Phase 1 | China | 16 Mar 2026 | |
| Pancreatic Adenoma | Phase 1 | China | 16 Mar 2026 | |
| Solid tumor | Preclinical | China | 30 Jun 2025 |





